280 results on '"Soave, Rosemary"'
Search Results
2. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients
3. Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients
4. 495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients
5. Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
6. Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
7. Prophylaxis Strategies for Solid-Organ Transplantation
8. Paromomycin: No More Effective than Placebo for Treatment of Cryptosporidiosis in Patients with Advanced Human Immunodeficiency Virus Infection
9. Cyclosporiasis: Clinical and Histopathologic Correlates
10. Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications
11. Cyclospora: An Overview
12. Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers
13. Acute hemolytic anemia after hematopoietic stem cell transplantation: An unusual invader
14. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
15. Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
16. A Care Coordination Program for Substance-Exposed Newborns
17. A Budding Headache in a Patient with Hematological Malignancy
18. Vulnerable Infants Program of Rhode Island : Promoting Permanency for Substance-Exposed Infants
19. Reply to Caldwell et al
20. Cryptosporidiosis
21. Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes
22. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens
23. Cryptosporidium and Cryptosporidiosis
24. Comprehensive Care Revisited
25. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients
26. Incidence of Adenovirus Viremia in Adult Allogeneic Transplant. Predictors of Severe Disease
27. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study
28. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
29. Clinical Characteristics and Risk Factors for Adverse Outcomes of Influenza Infections in Hematopoietic Stem Cell Transplant Recipients
30. 519. Immune responses and COVID-19 severity
31. 532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
32. Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
33. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir
34. Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
35. Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
36. Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients
37. 2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
38. A Post-Hoc Analysis of the Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Hematopoeitic Cell Transplant (HCT) Recipients with Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO)
39. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
40. Services used by perinatal substance-users with child welfare involvement: a descriptive study
41. So Many Possibilities: Lung Nodules in a Transplant Recipient
42. Cyclospora: conquest of an emerging pathogen
43. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
44. Cryptosporidium Infection and CD4 Counts
45. 451 - Incidence of Adenovirus Viremia in Adult Allogeneic Transplant. Predictors of Severe Disease
46. Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.
47. DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center
48. Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
49. 1589. Increased Detection of Diarrheal Pathogens in Hematopoietic Stem Cell Transplant Recipients Using a Multiplexed PCR Panel
50. 1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.